MondegarAI
StepStone Group LP

Q4 2024 · 13F-HR

StepStone Group LPholdings as filed

Filed 2025-02-13 · accession 0000950123-25-001948

$114.4M
Reported value
14
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
60938K304MONEYLION, INC.$53.6M46.8%622,931CommonSOLE
90364P105PATHUIPATH, INC.$16.4M14.3%1,286,527CommonSOLE
29384C108TRDAENTRADA THERAPEUTICS, INC.$13.2M11.5%761,277CommonSOLE
26142V105DKNGDRAFTKINGS INC$12.0M10.5%321,804CommonSHARED
68277Q105OKURONKURE THERAPEUTICS INC$4.2M3.70%491,938CommonSOLE
10920V404NEUEHEALTH INC.$3.9M3.41%525,247CommonSOLE
71722W107PHATPHATHOM PHARMACEUTICALS, INC.$3.4M3.00%422,085CommonSOLE
19260Q107COINCOINBASE GLOBAL INC$3.3M2.88%13,281CommonSOLE
43157M102HILLEVAX, INC.$1.7M1.50%826,569CommonSOLE
8173OH109SENTINELONE INC$784,2370.69%35,326CommonSOLE
91854V206VACASA, INC.$721,5790.63%147,261CommonSOLE
87990A106TNYATENAYA THERAPEUTICS, INC.$660,8930.58%462,163CommonSOLE
39957D201GROVGROVE COLLABORATIVE HOLDINGS, INC.$528,7320.46%380,383CommonSOLE
75134P600METCRAMACO RES INC$38,8550.03%3,787CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.